Europe and North America are driving expansion of bio-based polymer and bio-based building block capacity while Asia remains ...

Bio-based polyhydroxyalkanoates (PHAs) are considered one of the most promising sustainable alternatives to fossil-derived plastics. Poly[(D-lactate)-co-(R)-3-hydroxybutyrate] (LAHB) is an ...

PHILADELPHIA--(BUSINESS WIRE)--Braskem (B3: BRKM3, BRKM5, and BRKM6; NYSE: BAK; LATIBEX: XBRK), a global market leader and pioneer producer of bio-polyethylene, proudly celebrates the 15 th ...

That doesn’t make the effort futile. It places it in context. Bio-based foams represent one strategy among many: redesign packaging, reduce unnecessary cushioning, regulate the worst offenders, and ...

From sugarcane to innovative solutions for the nonwoven market, evolving supply capabilities, and introducing new features to better serve our clients. PHILADELPHIA--(BUSINESS WIRE)--Braskem (B3: ...

Braskem, a market leader in the production of biopolymers on an industrial scale, is currently at K 2025, the world’s leading trade fair for plastics and rubber in Düsseldorf, Germany. On the opening ...

ZAG Ski’s progressive redesigns have resulted in a prototype product that features 80% bio-based content and is compatible with industrial production.

European Union (EU) legislation mandating certain levels of plastic recyclate content in automobiles is leading to accelerated initiatives by automakers to develop materials and infrastructure to ...

Diisocyanates are used in the preparation of all polyurethanes, ranging from the foams used in shoe soles to the thermoplastics used in cell phone cases. Aromatic diisocyanates, which give ...

Scientists have made a revolutionary breakthrough in bio-based materials. According to a study published in the journal Sustainability, the researchers were able to create a new pineapple leather that ...

The premium alternative to plastic frames is gaining momentum across the United States Cheap plastic sunglasses are qu ...

SOMERVILLE, Mass.--(BUSINESS WIRE)-- bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird bio”) today announced it has signed its first Medicaid outcomes-based agreement for LYFGENIA™ (lovotibeglogene ...